AKT inhibitors in research and application
AKT inhibitors in research and application
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression
Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Results from CheckMate-227 : Immune combination reaches PFS endpoint
Editor's Choice for February 2018
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer
Immunotherapy and targeted treatments in breast cancer reviewed
The best sequence of anti-HER2 therapy in metastatic breast cancer
ESO-ESMO-ABC guidelines in metastatic breast cancer
BGICC conference highlights: Changing standards in breast and gynaecological cancers
Management of inflammatory breast cancer